...
首页> 外文期刊>Journal of Clinical Microbiology >Adaptive Resistance to Biocides in Salmonella enterica and Escherichia coli O157 and Cross-Resistance to Antimicrobial Agents
【24h】

Adaptive Resistance to Biocides in Salmonella enterica and Escherichia coli O157 and Cross-Resistance to Antimicrobial Agents

机译:对小肠沙门氏菌和大肠杆菌O157中杀生物剂的适应性耐药以及对抗菌剂的交叉耐药性

获取原文
           

摘要

The mechanisms by which bacteria resist killing by antibiotics and biocides are still poorly defined, although repeated exposure to sublethal concentrations of antibacterial agents undoubtedly contributes to their development. This study aimed both to investigate the potential of Salmonella enterica and Escherichia coli O157 for adaptive resistance to commonly used biocides and to determine any cross-resistance to antibiotics. Strains were repeatedly passaged in media containing increasing concentrations of a biocide or antibiotic until adaptive resistance was obtained. A wide panel of antimicrobial agents was then screened by using the adapted strain to determine cross-resistance, if any. Adaptive resistance was readily achieved for both S. enterica and E. coli O157. Cross-resistance in adaptively resistant S. enterica varied with the serotype; Salmonella enterica serovar Enteritidis expressed cross-resistance to chloramphenicol, whereas Salmonella enterica serovar Typhimurium expressed cross-resistance to chlorhexidine. Benzalkonium chloride-resistant Salmonella enterica serovar Virchow showed elevated resistance to chlorhexidine; however, chlorhexidine-resistant Salmonella serovar Virchow did not demonstrate reciprocal cross-resistance to benzalkonium chloride, suggesting specific rather than generic resistance mechanisms. E. coli O157 strains acquired high levels of resistance to triclosan after only two sublethal exposures and, when adapted, repeatedly demonstrated decreased susceptibilities to various antimicrobial agents, including chloramphenicol, erythromycin, imipenem, tetracycline, and trimethoprim, as well as to a number of biocides. These observations raise concern over the indiscriminate and often inappropriate use of biocides, especially triclosan, in situations where they are unnecessary, whereby they may contribute to the development of microbial resistance mechanisms.
机译:尽管细菌反复暴露于致死浓度以下的抗菌剂无疑有助于其发展,但细菌抵抗抗生素和杀生物剂杀伤的机制仍知之甚少。这项研究旨在调查沙门氏菌大肠杆菌 O157对常用杀生物剂的适应性耐药性,并确定对抗生素的任何交叉耐药性。菌株在含有增加浓度的杀生物剂或抗生素的培养基中反复传代,直到获得适应性抗性。然后通过使用适应性菌株筛选宽泛的抗菌剂,以确定交叉耐药性(如果有)。对于这两个 S,很容易获得适应性抗性。 enterica E。大肠杆菌O157。自适应抗性 S中的交叉抗性。肠炎随血清型而变化;肠炎沙门氏菌肠炎沙门氏菌对氯霉素具有交叉耐药性,肠溶沙门氏菌肠炎沙门氏菌对洗必太具有交叉耐药性。耐苯扎氯铵的沙门氏菌血清型Virchow对氯己定的耐药性升高;然而,耐洗必泰的沙门氏菌沙门氏菌Virchow并未表现出对苯扎氯铵的相互交叉耐药性,这表明它具有特异性而非通用的耐药性机制。 E。大肠杆菌O157菌株仅在两次亚致死性暴露后才获得高水平的三氯生抗药性,经过适应后,反复证明其对各种抗菌剂(包括氯霉素,红霉素,亚胺培南,四环素和甲氧苄啶)的敏感性降低。杀菌剂的数量。这些观察结果引起人们的关注,即在不必要的情况下会不必要地滥用杀生物剂,尤其是三氯生,从而可能促进微生物耐药性机制的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号